Lyme disease is the most common vector-borne disease in the U.S. It caused by infection with the bacterium Borrelia burgdorferi. The condition can cause facial palsy, severe headaches, swelling in large joints, shooting pains, and changes in heartbeat if not initially treated with antibiotics. Lyme disease symptoms can mimic many other illnesses and have been linked to several autoimmune diseases.
The New Tactics of Lyme Disease Diagnostics Market Report provides a thorough analysis of the market in terms of value, volume, CAGR, and year-over-year growth. The analysis predicts that new tools and technological development will propel business growth in the near future, by 2028.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
Major players operating in the global Lyme disease diagnostics market include, Immunetics Inc., Abbott Laboratories, T2 Biosystems, Affymetrix Inc., Siemens AG, Alere Inc., Roche Diagnostics International Ltd., Baxter International Inc., GlaxoSmithKline Pharmaceuticals Ltd., Bio-Rad Laboratories, Fresenius Medical Care AG & Co., Boulder Diagnostics, Covance Inc., and Canon Life Sciences.
Key Market Drivers:
R&D of new therapies is expected to propel growth of the global Lyme disease diagnostics market over the forecast period. For instance, in November 2021, researchers from Yale University reported development of an mRNA vaccine against lyme disease that triggers an immune response at the site of a tick bite and provides partial protection against the disease-causing bacteria.
Moreover, increasing incidence of Lyme disease is also expected to aid in growth of the global Lyme disease diagnostics market. For instance, in November 2021, Ohio Department of Health, U.S. reported 484 Lyme disease cases so far in 2021 among Ohio residents, which was an increase from 468 cases reported in 2019.
Covid-19 Impact Analysis
The emergence of Covid-19 has led to R&D of new testing methods that demonstrate potential advantages over conventional testing methods in SARS-CoV-2 and Lyme disease. For instance, in October 2021, Adaptive Biotechnologies Corporation announced to present new data that shows the ability of its immune medicine platform to distinguish between SARS-CoV-2 infection and vaccine response and detect Lyme disease.
Request PDF Brochure with Latest Insights @
Major players operating in the global Lyme disease diagnostics market are focused on R&D to expand their product portfolio. For instance, in July 2020, Adaptive Biotechnologies Corp. launched ImmuneSense Lyme, a research study to inform the development of an improved test to detect Lyme disease in the early stages of an infection.
Lyme Disease Diagnostics Market Taxonomy
On the basis of diagnostics test, the Lyme disease diagnostics market is segmented into:
- Enzyme Linked Immunosorbent Assay (ELISA)
- Western Blot
On the basis of end user, the Lyme disease diagnostics market is segmented into:
- Diagnostic Laboratories
On the basis of region, the Lyme disease diagnostics market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Reasons to Buy this Lyme Disease Diagnostics Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Lyme Disease Diagnostics market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Lyme Disease Diagnostics market
➡Leading company profiles reveal details of key Lyme Disease Diagnostics market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Lyme Disease Diagnostics market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
𝐋𝐈𝐌𝐈𝐓𝐄𝐃 𝐓𝐈𝐌𝐄 𝐎𝐅𝐅𝐄𝐑 – 𝐇𝐮𝐫𝐫𝐲 𝐔𝐩 !!!
𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎%
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/1608
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Lyme Disease Diagnostics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Lyme Disease Diagnostics Industry Impact
Chapter 2 Global Lyme Disease Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Lyme Disease Diagnostics (Volume and Value) by Type
2.3 Global Lyme Disease Diagnostics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Lyme Disease Diagnostics Sales, Consumption, Export, Import by Regions
Chapter 5 North America Lyme Disease Diagnostics Market Analysis
Chapter 6 East Asia Lyme Disease Diagnostics Market Analysis
Chapter 7 Europe Lyme Disease Diagnostics Market Analysis
Chapter 8 South Asia Lyme Disease Diagnostics Market Analysis
Chapter 9 Southeast Asia Lyme Disease Diagnostics Market Analysis
Chapter 10 Middle East Lyme Disease Diagnostics Market Analysis
Chapter 11 Africa Lyme Disease Diagnostics Market Analysis
Chapter 12 Oceania Lyme Disease Diagnostics Market Analysis
Chapter 13 South America Lyme Disease Diagnostics Market Analysis
Chapter 14 Company Profiles and Key Figures in Lyme Disease Diagnostics Business
Chapter 15 Global Lyme Disease Diagnostics Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027